Results 151 to 160 of about 20,100 (304)

Eculizumab in Acute Recurrence of Thrombotic Microangiopathy After Renal Transplantation [PDF]

, 2011
Karine Hadaya, Sylvie Ferrari‐Lacraz, D. Fumeaux, Françoise Boehlen, Christian Toso, Solange Moll, P.-Y. Martin, Jean Villard   +7 more
openalex   +1 more source

Eculizumab in myasthenia gravis: A review

Saudi Journal of Ophthalmology
Abstract: Eculizumab, a monoclonal antibody against complement C5, is a novel therapy to treat refractory myasthenia gravis (MG). The present review was undertaken to study the role of eculizumab in MG. This includes the drug’s mechanism, pharmacokinetics, clinical trial findings, tolerability, side effects, safety, dosage, administration ...
Zhou, Avery, Ho, Sabrina, Vickers, Aroucha   +2 more
openaire   +2 more sources

Progression to end-stage renal disease is reduced with eculizumab in patients with atypical haemolytic uraemic syndrome [PDF]

, 2015
Harvey, Erwin, Johnson, Scott, Kincaid, John F, Vande Walle, Johan   +3 more
core   +2 more sources

Eculizumab in atypical haemolytic-uraemic syndrome allows cessation of plasma exchange and dialysis [PDF]

, 2012
Jon Jin Kim, Simon Waller, Christopher Reid   +2 more
openalex   +1 more source

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Clinical Pharmacology: Advances and Applications, 2011
Maro Ohanian, Christian Cable, Kathleen HalkaDepartment of Hematology and Oncology, Scott and White Healthcare, The Texas A&M Health Science Center College of Medicine, Temple, TX, USAAbstract: This case report describes how eculizumab reversed ...
Ohanian M, Cable CC, Halka KK
doaj  

From perpetual haemosiderinuria to possible iron overload: iron redistribution in paroxysmal nocturnal haemoglobinuria patients on eculizumab by magnetic resonance imaging [PDF]

, 2012
Antonio M. Risitano, Massimo Imbriaco, Ludovica Marando, Elisa Seneca, Ernesto Soscia, Luca Malcovati, Anna Paola Iori, Fabrizio Pane, Rosario Notaro, Margherita Matarazzo   +9 more
openalex   +1 more source

Eculizumab in paroxysmal nocturnal hemoglobinuria with Budd-Chiari syndrome progressing despite anticoagulation [PDF]

, 2012
Andrés Brodsky, Octavio Mazzocchi, F. J. Gómez de Terreros Sánchez, Gus Khursigara, Suneil S. Malhotra, Mariano Volpacchio   +5 more
openalex   +1 more source

Eculizumab Therapy [PDF]

Biology of Blood and Marrow Transplantation, 2014
openaire   +2 more sources

Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy

Kidney Medicine, 2020
In patients with pregnancy-associated complement gene variant–mediated thrombotic microangiopathy (cTMA), terminal complement blockade is used for treatment of cTMA flares during pregnancy or following delivery.
Natalja Haninger-Vacariu, Christof Aigner, Renate Kain, Zoltán Prohászka, Martina Gaggl, Georg A. Böhmig, Leah Charlotte Piggott, Raute Sunder-Plassmann, Gere Sunder-Plassmann, Alice Schmidt   +9 more
doaj  

Thrombotic complications without evidence of hemolysis in paroxysmal nocturnal hemoglobinuria: is eculizumab indicated? [PDF]

, 2012
Mar Bellido, Vincent H. J. van der Velden, Frank W.G. Leebeek, Peter te Boekhorst   +3 more
openalex   +1 more source